Categories: HealthcareNews

LexisNexis Risk Solutions Launches Research-Ready Healthcare Data Blends to Expedite Research

Blended, patient-level datasets leveraging proprietary tokenization technology simplify data enrichment while adhering to privacy standards

ATLANTA, Jan. 29, 2025 /PRNewswire/ — LexisNexis® Risk Solutions, a leading provider of healthcare analytics and insights, today announced the launch of new research-ready, real-world datasets designed to accelerate research timelines, reduce costs and enable more equitable analyses. Using referential-based tokenization, the patient-level datasets are blended, expert determined and certified ensuring they are standardized and research ready. This process gives research teams a more simplified way to enrich their datasets or define a cohort of interest to support specific study objectives, including benchmarking with comparator cohorts. These datasets integrate into clinical research workflows, generating impactful real-world evidence to accelerate innovation and speed-to-market.

“By offering comprehensive, research-ready datasets that are standardized, expert determined and ready for immediate use, we’re enabling researchers to eliminate traditional data management challenges and accelerate their timeline to deliver actionable insights,” said Adam Mariano, president and general manager of healthcare, LexisNexis Risk Solutions. “We’re empowering research teams with a more efficient way to create more holistic and unbiased datasets, so they can uncover health disparities, develop personalized treatments, and ultimately improve patient outcomes across diverse populations.”

The new, expert determined data blends include two or more of the following datasets:

  • Care Delivery Insights: 
    • Healthcare utilization insights from de-identified open and closed medical, pharmacy and lab claims including diagnoses, comorbidities, service date, place of service, service codes and modifiers
    • Pharmacy/medication insights, including drug name, code, quantity and dosage
    • Financial insights, including details on the total cost of care
  • Social determinants of health (SDOH):
    • Factors such as transportation risks, financial challenges and proximity to care
    • Insights on disparities in healthcare access based on urban/rural settings, food deserts, and race/ethnicity
  • Mortality Insights: 
    • Derived from non-traditional sources and updated weekly

The data blends also provide a longitudinal view across all settings of care and all populations, reducing potential biases from single-source data. Advanced subgroup analyses enable researchers to identify distinct patient populations with unique treatment responses, fostering personalized care and more effective therapeutics and care delivery models. Furthermore, the data blends support proactive monitoring to identify high-risk populations, reduce adverse events, and facilitate patient assistance programs by addressing financial and logistical challenges.

For more information about the new research-ready datasets, visit https://risk.lexisnexis.com/.

About LexisNexis Risk Solutions
LexisNexis Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, healthcare and government. Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX (LSE: REL/NYSE: RELX), a global provider of information and analytics for professional and business customers. For more information, please visit www.risk.lexisnexis.com and www.relx.com.

Media Contact: 
Syed Shabbir
Sr. Manager, Corporate Communications
LexisNexis Risk Solutions  
816-572-7709  
syed.shabbir@lexisnexisrisk.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lexisnexis-risk-solutions-launches-research-ready-healthcare-data-blends-to-expedite-research-302362719.html

SOURCE LexisNexis Risk Solutions

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

20 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

20 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago